NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) Fundamental Analysis & Valuation

TSX:NWH-DB-I • CA667495AK14

103.62 CAD
+0.01 (+0.01%)
Last: Mar 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis News

This NWH-DB-I.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall NWH-DB-I gets a fundamental rating of 3 out of 10. We evaluated NWH-DB-I against 33 industry peers in the Diversified REITs industry. Both the profitability and the financial health of NWH-DB-I get a neutral evaluation. Nothing too spectacular is happening here. NWH-DB-I has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. NWH-DB-I.CA Profitability Analysis

1.1 Basic Checks

  • NWH-DB-I had negative earnings in the past year.
  • In the past year NWH-DB-I had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: NWH-DB-I reported negative net income in multiple years.
  • NWH-DB-I had a positive operating cash flow in each of the past 5 years.
NWH-DB-I.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-I.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • NWH-DB-I has a Return On Assets of -1.53%. This is in the lower half of the industry: NWH-DB-I underperforms 63.64% of its industry peers.
  • NWH-DB-I has a Return On Equity of -3.51%. This is in the lower half of the industry: NWH-DB-I underperforms 63.64% of its industry peers.
  • The Return On Invested Capital of NWH-DB-I (6.96%) is better than 84.85% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NWH-DB-I is in line with the industry average of 5.71%.
  • The 3 year average ROIC (4.86%) for NWH-DB-I is below the current ROIC(6.96%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.53%
ROE -3.51%
ROIC 6.96%
ROA(3y)-3.68%
ROA(5y)-0.83%
ROE(3y)-13.37%
ROE(5y)-3.86%
ROIC(3y)4.86%
ROIC(5y)4.26%
NWH-DB-I.CA Yearly ROA, ROE, ROICNWH-DB-I.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • NWH-DB-I's Operating Margin of 60.45% is fine compared to the rest of the industry. NWH-DB-I outperforms 72.73% of its industry peers.
  • NWH-DB-I's Operating Margin has declined in the last couple of years.
  • NWH-DB-I has a better Gross Margin (73.87%) than 78.79% of its industry peers.
  • NWH-DB-I's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 60.45%
PM (TTM) N/A
GM 73.87%
OM growth 3Y-3.35%
OM growth 5Y-2.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.64%
GM growth 5Y-0.69%
NWH-DB-I.CA Yearly Profit, Operating, Gross MarginsNWH-DB-I.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NWH-DB-I.CA Health Analysis

2.1 Basic Checks

  • NWH-DB-I has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NWH-DB-I has been increased compared to 1 year ago.
  • NWH-DB-I has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NWH-DB-I has been reduced compared to a year ago.
NWH-DB-I.CA Yearly Shares OutstandingNWH-DB-I.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NWH-DB-I.CA Yearly Total Debt VS Total AssetsNWH-DB-I.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • NWH-DB-I has an Altman-Z score of 7.87. This indicates that NWH-DB-I is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 7.87, NWH-DB-I belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Debt to FCF ratio of NWH-DB-I is 9.19, which is on the high side as it means it would take NWH-DB-I, 9.19 years of fcf income to pay off all of its debts.
  • NWH-DB-I has a Debt to FCF ratio of 9.19. This is amongst the best in the industry. NWH-DB-I outperforms 84.85% of its industry peers.
  • A Debt/Equity ratio of 0.59 indicates that NWH-DB-I is somewhat dependend on debt financing.
  • NWH-DB-I has a better Debt to Equity ratio (0.59) than 84.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 9.19
Altman-Z 7.87
ROIC/WACC0.9
WACC7.77%
NWH-DB-I.CA Yearly LT Debt VS Equity VS FCFNWH-DB-I.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.20 indicates that NWH-DB-I may have some problems paying its short term obligations.
  • NWH-DB-I has a worse Current ratio (0.20) than 63.64% of its industry peers.
  • A Quick Ratio of 0.20 indicates that NWH-DB-I may have some problems paying its short term obligations.
  • The Quick ratio of NWH-DB-I (0.20) is worse than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
NWH-DB-I.CA Yearly Current Assets VS Current LiabilitesNWH-DB-I.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. NWH-DB-I.CA Growth Analysis

3.1 Past

  • NWH-DB-I shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.95%, which is quite impressive.
  • The Revenue for NWH-DB-I has decreased by -29.10% in the past year. This is quite bad
  • The Revenue has been growing slightly by 2.48% on average over the past years.
EPS 1Y (TTM)84.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1184.73%
Revenue 1Y (TTM)-29.1%
Revenue growth 3Y-1.99%
Revenue growth 5Y2.48%
Sales Q2Q%4.76%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-I.CA Yearly Revenue VS EstimatesNWH-DB-I.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
NWH-DB-I.CA Yearly EPS VS EstimatesNWH-DB-I.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. NWH-DB-I.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NWH-DB-I. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NWH-DB-I.CA Price Earnings VS Forward Price EarningsNWH-DB-I.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • NWH-DB-I's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, NWH-DB-I is valued expensively inside the industry as 87.88% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 173.71
EV/EBITDA 105.49
NWH-DB-I.CA Per share dataNWH-DB-I.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. NWH-DB-I.CA Dividend Analysis

5.1 Amount

  • NWH-DB-I has a Yearly Dividend Yield of 10.04%, which is a nice return.
  • Compared to an average industry Dividend Yield of 7.14, NWH-DB-I pays a better dividend. On top of this NWH-DB-I pays more dividend than 93.94% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, NWH-DB-I pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

  • The dividend of NWH-DB-I decreases each year by -17.05%.
  • NWH-DB-I does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-17.05%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • NWH-DB-I has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-145.73%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-I.CA Yearly Income VS Free CF VS DividendNWH-DB-I.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

More info and screens

Find the best dividend stocksShow peers with best dividend

NWH-DB-I.CA Fundamentals: All Metrics, Ratios and Statistics

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-I (3/9/2026, 7:00:00 PM)

103.62

+0.01 (+0.01%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-25
Earnings (Next)05-12
Inst Owners10.74%
Inst Owner ChangeN/A
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap25.90B
Revenue(TTM)422.52M
Net Income(TTM)-52.85M
Analysts52.73
Price Target107.98 (4.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.31
Dividend Growth(5Y)-17.05%
DP-145.73%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.72%
PT rev (3m)-10.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 61.31
P/FCF 173.71
P/OCF 171.52
P/B 17.19
P/tB 17.19
EV/EBITDA 105.49
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.6
FCFY0.58%
OCF(TTM)0.6
OCFY0.58%
SpS1.69
BVpS6.03
TBVpS6.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -3.51%
ROCE 8.95%
ROIC 6.96%
ROICexc 7.2%
ROICexgc 7.21%
OM 60.45%
PM (TTM) N/A
GM 73.87%
FCFM 35.29%
ROA(3y)-3.68%
ROA(5y)-0.83%
ROE(3y)-13.37%
ROE(5y)-3.86%
ROIC(3y)4.86%
ROIC(5y)4.26%
ROICexc(3y)4.96%
ROICexc(5y)4.34%
ROICexgc(3y)5.01%
ROICexgc(5y)4.4%
ROCE(3y)6.24%
ROCE(5y)5.48%
ROICexgc growth 3Y26.73%
ROICexgc growth 5Y11.24%
ROICexc growth 3Y27.57%
ROICexc growth 5Y11.66%
OM growth 3Y-3.35%
OM growth 5Y-2.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.64%
GM growth 5Y-0.69%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 9.19
Debt/EBITDA 3.43
Cap/Depr 84.64%
Cap/Sales 0.45%
Interest Coverage 1.97
Cash Conversion 58.61%
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z 7.87
F-Score5
WACC7.77%
ROIC/WACC0.9
Cap/Depr(3y)38.8%
Cap/Depr(5y)39%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1184.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.1%
Revenue growth 3Y-1.99%
Revenue growth 5Y2.48%
Sales Q2Q%4.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.18%
EBIT growth 3Y-5.28%
EBIT growth 5Y-0.08%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.88%
FCF growth 3Y-12.63%
FCF growth 5Y-4.59%
OCF growth 1Y74.31%
OCF growth 3Y-12.34%
OCF growth 5Y-4.37%

NORTHWEST HEALTHCARE PRO / NWH-DB-I.CA FAQ

Can you provide the ChartMill fundamental rating for NORTHWEST HEALTHCARE PRO?

ChartMill assigns a fundamental rating of 3 / 10 to NWH-DB-I.CA.


What is the valuation status of NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA). This can be considered as Overvalued.


Can you provide the profitability details for NORTHWEST HEALTHCARE PRO?

NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) has a profitability rating of 4 / 10.


What is the financial health of NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) stock?

The financial health rating of NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) is 4 / 10.